105 related articles for article (PubMed ID: 20025370)
1. Effects of transdermal nicotine on symptoms, moods, and cardiovascular activity in the everyday lives of smokers and nonsmokers with attention-deficit/hyperactivity disorder.
Gehricke JG; Hong N; Whalen CK; Steinhoff K; Wigal TL
Psychol Addict Behav; 2009 Dec; 23(4):644-55. PubMed ID: 20025370
[TBL] [Abstract][Full Text] [Related]
2. The reinforcing effects of nicotine and stimulant medication in the everyday lives of adult smokers with ADHD: A preliminary examination.
Gehricke JG; Whalen CK; Jamner LD; Wigal TL; Steinhoff K
Nicotine Tob Res; 2006 Feb; 8(1):37-47. PubMed ID: 16497598
[TBL] [Abstract][Full Text] [Related]
3. Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD).
Conners CK; Levin ED; Sparrow E; Hinton SC; Erhardt D; Meck WH; Rose JE; March J
Psychopharmacol Bull; 1996; 32(1):67-73. PubMed ID: 8927677
[TBL] [Abstract][Full Text] [Related]
4. Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits.
Poltavski DV; Petros T
Physiol Behav; 2006 Mar; 87(3):614-24. PubMed ID: 16466655
[TBL] [Abstract][Full Text] [Related]
5. Effects of transdermal nicotine on prose memory and attention in smokers and nonsmokers.
Poltavski DV; Petros T
Physiol Behav; 2005 Jan; 83(5):833-43. PubMed ID: 15639169
[TBL] [Abstract][Full Text] [Related]
6. Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder.
Potter AS; Newhouse PA
Pharmacol Biochem Behav; 2008 Feb; 88(4):407-17. PubMed ID: 18022679
[TBL] [Abstract][Full Text] [Related]
7. Nicotine patches and the subjective effects of cigarette smoking: a pilot study.
Cárdenas L; Busto UE; MacDonald A; Corrigall WA
Can J Clin Pharmacol; 2002; 9(4):175-82. PubMed ID: 12584575
[TBL] [Abstract][Full Text] [Related]
8. Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial.
Yudkin PL; Jones L; Lancaster T; Fowler GH
Br J Gen Pract; 1996 Mar; 46(404):145-8. PubMed ID: 8731618
[TBL] [Abstract][Full Text] [Related]
9. Preliminary evidence of the association between the history of childhood attention-deficit/hyperactivity disorder and smoking treatment failure.
Humfleet GL; Prochaska JJ; Mengis M; Cullen J; Muñoz R; Reus V; Hall SM
Nicotine Tob Res; 2005 Jun; 7(3):453-60. PubMed ID: 16085513
[TBL] [Abstract][Full Text] [Related]
10. [A double-blind trial of nicotine patches in smoking cessation].
Tønnesen P; Nørregaard J; Simonsen K; Säwe U
Ugeskr Laeger; 1992 Jan; 154(5):251-4. PubMed ID: 1736456
[TBL] [Abstract][Full Text] [Related]
11. Transdermal nicotine patch enhances type I collagen synthesis in abstinent smokers.
Sørensen LT; Jorgensen LN; Zillmer R; Vange J; Hemmingsen U; Gottrup F
Wound Repair Regen; 2006; 14(3):247-51. PubMed ID: 16808802
[TBL] [Abstract][Full Text] [Related]
12. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080
[TBL] [Abstract][Full Text] [Related]
13. Nicotine replacement therapy for patients with coronary artery disease. Working Group for the Study of Transdermal Nicotine in Patients with Coronary artery disease.
Arch Intern Med; 1994 May; 154(9):989-95. PubMed ID: 8179456
[TBL] [Abstract][Full Text] [Related]
14. Attention-Deficit Hyperactivity Disorder (ADHD) symptoms and smoking patterns among participants in a smoking-cessation program.
Lerman C; Audrain J; Tercyak K; Hawk LW; Bush A; Crystal-Mansour S; Rose C; Niaura R; Epstein LH
Nicotine Tob Res; 2001 Nov; 3(4):353-9. PubMed ID: 11694203
[TBL] [Abstract][Full Text] [Related]
15. [Effects of transdermal nicotine as an adjunct in smoking cessation therapy. A double-blind randomized study controlled with placebo].
Daughton DM; Heatley SA; Prendergast JJ; Causey D; Knowles M; Rolf CN; Cheney RA; Hatlelid K; Thompson AB; De Blasio F
Arch Monaldi Mal Torace; 1992; 47(1-6):17-29. PubMed ID: 1306633
[TBL] [Abstract][Full Text] [Related]
16. Acute effects of nicotine on attention and response inhibition.
Bekker EM; Böcker KB; Van Hunsel F; van den Berg MC; Kenemans JL
Pharmacol Biochem Behav; 2005 Nov; 82(3):539-48. PubMed ID: 16360813
[TBL] [Abstract][Full Text] [Related]
17. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers.
Ferguson SG; Gitchell JG; Shiffman S; Sembower MA
Clin Ther; 2009 Sep; 31(9):1957-65. PubMed ID: 19843485
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
[TBL] [Abstract][Full Text] [Related]
19. Effects of transdermally administered nicotine on aspects of attention, task load, and mood in women and men.
Trimmel M; Wittberger S
Pharmacol Biochem Behav; 2004 Jul; 78(3):639-45. PubMed ID: 15251273
[TBL] [Abstract][Full Text] [Related]
20. Naltrexone alteration of the nicotine-induced EEG and mood activation response in tobacco-deprived cigarette smokers.
Knott VJ; Fisher DJ
Exp Clin Psychopharmacol; 2007 Aug; 15(4):368-81. PubMed ID: 17696684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
